secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001193125-24-159094
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences 2024 annual meeting results: all proposals approved by shareholders
--------------------------------------------------------------------------------

- Elected Wenbin Jiang and Michael Holder as Class III directors with 64.2M and 70.3M votes for, respectively.
- Advisory vote on executive compensation approved: 63.5M for, 10.5M against, 78.9K abstentions.
- Ratified Deloitte & Touche LLP as independent auditor for FY2024: 94.1M for, 2.3M against, 656.7K abstentions.
- Approximately 74% of outstanding shares (97.1M of 131.3M) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/0001193125-24-159094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/d841203d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-159094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer